Itron, Inc. (NASDAQ:ITRI) – Investment analysts at Oppenheimer Holdings reduced their FY2017 EPS estimates for shares of Itron in a note issued to investors on Thursday. Oppenheimer Holdings analyst N. Kaye now expects that the scientific and technical instruments company will post earnings of $3.02 per share for the year, down from their previous estimate of $3.06. Oppenheimer Holdings has a “Outperform” rating and a $78.00 price objective on the stock. Oppenheimer Holdings also issued estimates for Itron’s Q4 2017 earnings at $0.97 EPS, FY2018 earnings at $3.57 EPS, FY2019 earnings at $4.47 EPS and FY2020 earnings at $5.38 EPS.

Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Wednesday, November 1st. The scientific and technical instruments company reported $0.77 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.89 by ($0.12). The firm had revenue of $486.75 million for the quarter, compared to analysts’ expectations of $526.55 million. Itron had a return on equity of 14.84% and a net margin of 3.42%. The firm’s revenue was down 4.0% on a year-over-year basis. During the same period last year, the company earned $0.77 earnings per share.

TRADEMARK VIOLATION NOTICE: This story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.thecerbatgem.com/2017/11/08/fy2017-eps-estimates-for-itron-inc-decreased-by-oppenheimer-holdings-itri.html.

Other analysts have also recently issued reports about the company. Cowen and Company set a $60.00 price objective on Itron and gave the stock a “hold” rating in a report on Friday, July 21st. Robert W. Baird reaffirmed a “hold” rating and set a $77.00 price objective on shares of Itron in a report on Tuesday, September 12th. BidaskClub cut Itron from a “strong-buy” rating to a “buy” rating in a report on Thursday, July 27th. Zacks Investment Research downgraded Itron from a “hold” rating to a “sell” rating in a research report on Monday. Finally, Needham & Company LLC reissued a “buy” rating and set a $84.00 target price (up previously from $74.00) on shares of Itron in a research report on Thursday, August 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $81.78.

Shares of Itron (NASDAQ ITRI) opened at $67.00 on Monday. The stock has a market capitalization of $2,687.53, a P/E ratio of 25.42, a PEG ratio of 1.10 and a beta of 1.07. Itron has a twelve month low of $57.80 and a twelve month high of $79.95. The company has a current ratio of 1.67, a quick ratio of 1.26 and a debt-to-equity ratio of 0.38.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. increased its position in shares of Itron by 2.0% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,610 shares of the scientific and technical instruments company’s stock valued at $109,000 after purchasing an additional 31 shares during the last quarter. Pacad Investment Ltd. increased its position in shares of Itron by 21.4% during the 2nd quarter. Pacad Investment Ltd. now owns 1,700 shares of the scientific and technical instruments company’s stock valued at $115,000 after purchasing an additional 300 shares during the last quarter. Riverhead Capital Management LLC grew its position in Itron by 74.8% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,097 shares of the scientific and technical instruments company’s stock valued at $142,000 after acquiring an additional 897 shares during the last quarter. SG Americas Securities LLC grew its position in Itron by 1.5% in the 1st quarter. SG Americas Securities LLC now owns 2,366 shares of the scientific and technical instruments company’s stock valued at $144,000 after acquiring an additional 36 shares during the last quarter. Finally, Royal Bank of Canada grew its position in Itron by 10.9% in the 2nd quarter. Royal Bank of Canada now owns 3,042 shares of the scientific and technical instruments company’s stock valued at $206,000 after acquiring an additional 299 shares during the last quarter. 93.54% of the stock is currently owned by hedge funds and other institutional investors.

About Itron

Itron, Inc (Itron) is a technology and service company. The Company provides solutions that measure, manage and analyze energy and water use. The Company operates through three segments: Electricity, Gas and Water. It provides a portfolio of products, solutions, software and services to electric, gas and water utility customers across the globe.

Earnings History and Estimates for Itron (NASDAQ:ITRI)

Receive News & Stock Ratings for Itron Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron Inc. and related stocks with our FREE daily email newsletter.